Teva, Mylan win FDA approval for first generic versions of Pfizer’s Celebrex


The US Food and Drug Administration has given the green light for Teva Pharmaceutical Industries and Mylan’s generic copies of Pfizer’s Celebrex. Celebrex (celecoxib) capsules provide a treatment for rheumatoid arthritis, osteoarthritis, short-term (acute) pain, and other conditions. “It is important for patients to have access to affordable treatment options for chronic conditions,” said Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research. “Health care professionals and patients can be assured that these FDA-approved generic drugs have met our rigorous approval standards.”

Read the source article at

About the Author

Leave a Reply